Pacific Biosciences of Californ

PACB

Healthcare · 1.26 -16.0% today

Participation confirmed · construction unavailableMarket checked 20 Aug, 09:30 GMT-4

Jodie situation report

Pacific Biosciences of Californ's move is spreading beyond its market group.

No new filing conclusion is available. 5 of 8 group members are active now; 1 filing-linked outsider is moving with the group, and 0 of 0 directly disclosed connections are confirming.

Company-16.0% todayVolume comparison unavailable

Market group5 of 8 activeGene Therapies · building

Disclosed network0 of 2 confirmingNo filing-linked name is confirming now

What would change this read

Participation spreads to CLNN, PACB, VERU.
Capital-flow agreement rises above 55%.
TXG remains aligned with the group in the next market snapshot.

Invalidation: The live read weakens if participation falls to 2 of 8 members or fewer.

Watch this read

Who this business touches

The relationships behind PACB

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Filing peers

WGSQSITWST

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

PACB is currently a Participant in the organic co-movement group Gene Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.